Visceral obesity, metabolic syndrome, insulin resistance and cancer

Explore this paper's citation graph

Summary

Emerging evidence linking visceral adiposity and the metabolic syndrome (MetSyn) with carcinogenesis is presented and it is clear from current research that excess visceral obesity and associated dysmetabolism play a central role in the pathogenesis of certain cancer types.

Type
article
Published
2011-11-03
Cited by
310
References
130
Access
Open access

Keywords

Insulin resistance, Adipose tissue, Metabolic syndrome, Adipokine, Internal medicine

References

Cited by

Related papers